SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-017201
Filing Date
2019-05-08
Accepted
2019-05-08 16:12:14
Documents
3
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q1 2019 EARNINGS 8-K snss-8k_20190508.htm 8-K 33223
2 EX-99.1 snss-ex991_6.htm EX-99.1 225535
3 GRAPHIC giyj2ilk20pm000001.jpg GRAPHIC 2773
  Complete submission text file 0001564590-19-017201.txt   264012
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 19806731
SIC: 2834 Pharmaceutical Preparations